ADHD Psychiatric Disorder Risk Affected by Dysregulation of RNA-Binding Proteins Using a deep learning approach to study mutations in target sites of RNA-binding proteins, researchers identified DDHD2 as a candidate schizophrenia risk gene. Psychiatric Disorders Fall Into Groups With Shared Genetic Contributors in GWAS Meta-Analysis A genome-wide association study meta-analysis of eight psychiatric conditions led to new and known risk loci, and revealed three distinct groups of conditions. Genetic Links Between Psychotic Experiences, Neuropsychiatric Diseases Uncovered in Study Researchers also uncovered associations between any psychotic experience and the genetic liability for schizophrenia, major depressive disorder, and bipolar disorder. ADHD Risk Variants Identified Genome-wide association and meta-analyses have uncovered a dozen ADHD-related loci, providing insights into its biology and overlap with other conditions. Large Study Uncovers Genetic Connections Between Numerous Psychiatric Disorders This could mean that clinical boundaries between psychiatric disorders might not reflect their underlying biology, Brainstorm Consortium researchers said. May 31, 2018 Rare Truncating Mutations Play Role in Neurodevelopmental Disease Apr 21, 2017 Aevi Genomic Medicine IDs Best Responder Subset For ADHD Drug Premium Dec 8, 2016 Pediatric ADHD Study Shows Rare Genetic Mutation Underlies Condition in Some Patients Premium Dec 5, 2016 Six Loci Linked to Personality Traits in Meta-Analysis Jan 27, 2016 Researchers Uncover 17 Novel Genes Related to Developmental Brain Disorders May 21, 2014 Assurex Secures $25M Credit Facility, Nabs $7M Investment Sep 12, 2013 Consortium Receives $8M to Investigate Molecular Roots of Extreme Aggression May 9, 2012 MDx/CDx Focus: AssureRx Launches ADHD PGx Test; Adcetris Phase III Study in CD-30 Lymphoma; CardioDx Premium Mar 19, 2012 Denmark Heads $21.5M Psychiatric Consortium that Includes BGI and Decode Mar 14, 2012 CHOP's Joint Genome Center Turns to Sequencing for MDx and Drug Repositioning Premium Jul 27, 2011 Exome Sequencing Highlights Ethical Issues of Searching for Disease-Causing Mutations in Patients Premium Oct 5, 2010 Study Suggests Mutations in Maternal Serotonin Genes Can Influence Children's ADHD Symptoms Apr 6, 2009 BioRegion Real Estate: Apr 6, 2009 Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.